On-Demand Webinars

  1. Setting A New Standard For Biotech Program Visibility 5/27/2026

    Biotech visibility improves through real-time data and centralized platforms, enabling collaboration, faster decisions, reduced risk, and better partner alignment.

  2. In Vivo CAR-T And Gene Editing: Manufacturing Reality Behind The Promise 5/27/2026

    Gain practical insights into the manufacturing realities shaping in vivo CAR-T development and learn how leading teams are addressing the challenges of scaling both LNP and viral vector platforms."

  3. mAb Aggregate Control On-Demand Webinar 5/22/2026

    Aggregation can undermine yield and quality in downstream mAb processing. Learn practical capture, polishing, and TFF strategies to prevent and reduce aggregates, with a focus on chromatography.

  4. Straight From The Source: A Live Q&A With The Inventors Of KinetiSol™ 5/22/2026

    Experts discuss a solvent-free fusion process for amorphous solid dispersions, highlighting formulation flexibility, scale-up, process control, and early strategies to reduce risk and support commercialization.

  5. How Iteration And Operational Readiness Accelerate Product-To-Patient 5/20/2026

    See how an iterative, risk‑based approach to Commissioning & Qualification shifts verification earlier, reduces late‑stage pressure, and supports smoother startups through operational readiness.

  6. Cell And Gene Therapies – U.S. Payer Trends 5/20/2026

    Gain insights from U.S. payer interviews covering coverage processes, evidence requirements, and engagement strategies to accelerate market access from late-stage development through commercialization.

  7. The Transformative Potential Of AI In HEOR And Market Access 5/20/2026

    HEOR teams are under pressure to move faster without sacrificing rigor. Discover how AI accelerates evidence synthesis, fills data gaps, and supports living models that meet HTA transparency standards.

  8. The Evolving Policy Landscape: U.S. And EU Pricing And Access 5/20/2026

    U.S. and EU policy shifts are reshaping pricing, access, and launch strategy. Hear expert analysis on IRA, MFN, 340B, EU HTA Regulation, and the Biotech Act to stay ahead of 2025-2026 changes.

  9. Building The Right Foundation - Live Cell Assays In Clinical Trials 5/19/2026

    Watch Thomas (TJ) Beadnell share expert insights on developing robust live cell assays for global clinical trials, including best practices for assay logistics, antigen stability, and sample integrity.

  10. A Blueprint For Clinical-Grade Gene Therapy Production 5/19/2026

    View a scalable, open-access AAV9 manufacturing process improving yield, purity, and consistency through optimized transfection and downstream purification for clinical-grade gene therapy production.